Bio Protocol vs HeyElsa — how do they compare? Bio Protocol trades at Rp438.04 (market cap Rp999,49M, Rp162,68M 24h volume), while HeyElsa trades at Rp835.15 (market cap Rp232,13M, Rp35,97M 24h volume). The key difference: Bio Protocol is far larger — about 4.3× HeyElsa's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 255,6M / 1B ELSA (26%) for HeyElsa. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and HeyElsa for 6 Days on average.
| BIO | ELSA | |
|---|---|---|
Market Cap | Rp999,49M | Rp232,13M |
Volume (24h) | Rp162,68M | Rp35,97M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 255,6M / 1B ELSA (26%) |
Typical Hold Time | 18 Days | 6 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
HeyElsa (ELSA) is trading at Rp927.41 with a bearish technical signal, positioned near the pivot point of Rp924. The asset has a market cap of Rp239.34 million and a circulating supply of 255,600 tokens out of a maximum 1 million, indicating a 26% circulation rate. No major protocol updates or ecosystem developments were noted recently.
Overall outlook is cautious due to bearish technicals and limited liquidity. Key opportunities include potential rebounds from support levels, but risks involve low market cap volatility and lack of recent fundamental catalysts. Investors should monitor trading volume and on-chain activity for signs of momentum shifts.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →HeyElsa is an AI crypto assistant that converts natural-language commands into optimized on-chain actions. It enables intent-based execution for tasks like swaps and staking, handles routing and risk checks, and supports multiple chains including Ethereum, Solana, and Base. The platform also offers MPC wallets and onboarding tools to simplify DeFi for new users.
Read more on ELSA →